#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Finding critical in vitro and/or in silico parameters ( descriptors or properties ) of the hit→lead→seed→drug route is still a long-term aspiration and monumental challenge in drug discovery projects , mainly due to the intrinsic multidimensionality of the problem .
2-1	16-23	Finding	_	_	_	_
2-2	24-32	critical	abstract[4]	new[4]	appos	2-10[0_4]
2-3	33-35	in	abstract[4]	new[4]	_	_
2-4	36-41	vitro	abstract|abstract[4]	new|new[4]	_	_
2-5	42-48	and/or	abstract[4]	new[4]	_	_
2-6	49-51	in	abstract[4]	new[4]	_	_
2-7	52-58	silico	place|abstract[4]	new|new[4]	coref	16-30
2-8	59-69	parameters	abstract[4]	new[4]	_	_
2-9	70-71	(	_	_	_	_
2-10	72-83	descriptors	abstract|abstract[6]	giv|giv[6]	appos|appos	2-10[6_0]|2-12[0_6]
2-11	84-86	or	abstract[6]	giv[6]	_	_
2-12	87-97	properties	abstract[6]|abstract	giv[6]|giv	coref	3-39[28_0]
2-13	98-99	)	_	_	_	_
2-14	100-102	of	_	_	_	_
2-15	103-106	the	abstract[9]	new[9]	_	_
2-16	107-125	hit→lead→seed→drug	person|abstract[9]	new|new[9]	_	_
2-17	126-131	route	abstract[9]	new[9]	_	_
2-18	132-134	is	_	_	_	_
2-19	135-140	still	abstract[10]	new[10]	_	_
2-20	141-142	a	abstract[10]	new[10]	_	_
2-21	143-152	long-term	abstract[10]	new[10]	_	_
2-22	153-163	aspiration	abstract[10]	new[10]	_	_
2-23	164-167	and	_	_	_	_
2-24	168-178	monumental	abstract[11]	new[11]	_	_
2-25	179-188	challenge	abstract[11]	new[11]	_	_
2-26	189-191	in	abstract[11]	new[11]	_	_
2-27	192-196	drug	abstract[11]|substance|abstract[13]|abstract[14]	new[11]|new|new[13]|new[14]	coref|coref|coref	15-8|16-46[153_13]|16-46[154_14]
2-28	197-206	discovery	abstract[11]|abstract[13]|abstract[14]	new[11]|new[13]|new[14]	_	_
2-29	207-215	projects	abstract[11]|abstract[14]	new[11]|new[14]	_	_
2-30	216-217	,	abstract[11]	new[11]	_	_
2-31	218-224	mainly	abstract[11]|abstract[15]	new[11]|new[15]	_	_
2-32	225-228	due	abstract[11]|abstract[15]	new[11]|new[15]	_	_
2-33	229-231	to	abstract[11]|abstract[15]	new[11]|new[15]	_	_
2-34	232-235	the	abstract[11]|abstract[15]	new[11]|new[15]	_	_
2-35	236-245	intrinsic	abstract[11]|abstract[15]	new[11]|new[15]	_	_
2-36	246-265	multidimensionality	abstract[11]|abstract[15]	new[11]|new[15]	_	_
2-37	266-268	of	abstract[11]|abstract[15]	new[11]|new[15]	_	_
2-38	269-272	the	abstract[11]|abstract[15]|abstract[16]	new[11]|new[15]|new[16]	_	_
2-39	273-280	problem	abstract[11]|abstract[15]|abstract[16]	new[11]|new[15]|new[16]	_	_
2-40	281-282	.	_	_	_	_

#Text=In concert with the medicinal chemist ’s intuition ( or serendipity ) , the computer-assisted molecular design ( CAMD ) approaches are regarded as an integral method for the exhaustive transformation of the compound topology or topography and/or the electronic properties into the property-based chemical space .
3-1	283-285	In	_	_	_	_
3-2	286-293	concert	_	_	_	_
3-3	294-298	with	_	_	_	_
3-4	299-302	the	abstract[18]	new[18]	_	_
3-5	303-312	medicinal	person[17]|abstract[18]	new[17]|new[18]	_	_
3-6	313-320	chemist	person[17]|abstract[18]	new[17]|new[18]	_	_
3-7	321-323	’s	person[17]|abstract[18]	new[17]|new[18]	_	_
3-8	324-333	intuition	abstract[18]	new[18]	_	_
3-9	334-335	(	_	_	_	_
3-10	336-338	or	_	_	_	_
3-11	339-350	serendipity	abstract	new	_	_
3-12	351-352	)	_	_	_	_
3-13	353-354	,	_	_	_	_
3-14	355-358	the	abstract[20]	new[20]	appos	3-19[0_20]
3-15	359-376	computer-assisted	abstract[20]	new[20]	_	_
3-16	377-386	molecular	abstract[20]	new[20]	_	_
3-17	387-393	design	abstract[20]	new[20]	_	_
3-18	394-395	(	_	_	_	_
3-19	396-400	CAMD	abstract	giv	_	_
3-20	401-402	)	_	_	_	_
3-21	403-413	approaches	abstract	new	_	_
3-22	414-417	are	_	_	_	_
3-23	418-426	regarded	_	_	_	_
3-24	427-429	as	_	_	_	_
3-25	430-432	an	abstract[23]	new[23]	_	_
3-26	433-441	integral	abstract[23]	new[23]	_	_
3-27	442-448	method	abstract[23]	new[23]	_	_
3-28	449-452	for	abstract[23]	new[23]	_	_
3-29	453-456	the	abstract[23]|abstract[24]	new[23]|new[24]	_	_
3-30	457-467	exhaustive	abstract[23]|abstract[24]	new[23]|new[24]	_	_
3-31	468-482	transformation	abstract[23]|abstract[24]	new[23]|new[24]	_	_
3-32	483-485	of	abstract[23]|abstract[24]	new[23]|new[24]	_	_
3-33	486-489	the	abstract[23]|abstract[24]|abstract[26]	new[23]|new[24]|new[26]	_	_
3-34	490-498	compound	abstract[23]|abstract[24]|substance|abstract[26]	new[23]|new[24]|new|new[26]	coref	21-37
3-35	499-507	topology	abstract[23]|abstract[24]|abstract[26]	new[23]|new[24]|new[26]	_	_
3-36	508-510	or	abstract[23]|abstract[24]	new[23]|new[24]	_	_
3-37	511-521	topography	abstract[23]|abstract[24]|abstract	new[23]|new[24]|new	_	_
3-38	522-528	and/or	abstract[23]|abstract[24]	new[23]|new[24]	_	_
3-39	529-532	the	abstract[23]|abstract[24]|abstract[28]	new[23]|new[24]|giv[28]	coref	14-24[124_28]
3-40	533-543	electronic	abstract[23]|abstract[24]|abstract[28]	new[23]|new[24]|giv[28]	_	_
3-41	544-554	properties	abstract[23]|abstract[24]|abstract[28]	new[23]|new[24]|giv[28]	_	_
3-42	555-559	into	abstract[23]|abstract[24]	new[23]|new[24]	_	_
3-43	560-563	the	abstract[23]|abstract[24]|abstract[29]	new[23]|new[24]|new[29]	_	_
3-44	564-578	property-based	abstract[23]|abstract[24]|abstract[29]	new[23]|new[24]|new[29]	_	_
3-45	579-587	chemical	abstract[23]|abstract[24]|abstract[29]	new[23]|new[24]|new[29]	_	_
3-46	588-593	space	abstract[23]|abstract[24]|abstract[29]	new[23]|new[24]|new[29]	_	_
3-47	594-595	.	_	_	_	_

#Text=The systematic observational of trends of structural chemical modifications that produce corresponding changes in the biological responses for a congeneric series of molecules are fundamental for the multidimensional quantitative structure – activity ( mD-QSAR ) studies .
4-1	596-599	The	abstract[30]	new[30]	_	_
4-2	600-610	systematic	abstract[30]	new[30]	_	_
4-3	611-624	observational	abstract[30]	new[30]	_	_
4-4	625-627	of	abstract[30]	new[30]	_	_
4-5	628-634	trends	abstract[30]|abstract[31]	new[30]|new[31]	_	_
4-6	635-637	of	abstract[30]|abstract[31]	new[30]|new[31]	_	_
4-7	638-648	structural	abstract[30]|abstract[31]|abstract[32]	new[30]|new[31]|new[32]	coref	21-32[214_32]
4-8	649-657	chemical	abstract[30]|abstract[31]|abstract[32]	new[30]|new[31]|new[32]	_	_
4-9	658-671	modifications	abstract[30]|abstract[31]|abstract[32]	new[30]|new[31]|new[32]	_	_
4-10	672-676	that	abstract[30]|abstract[31]|abstract[32]	new[30]|new[31]|new[32]	_	_
4-11	677-684	produce	abstract[30]|abstract[31]|abstract[32]	new[30]|new[31]|new[32]	_	_
4-12	685-698	corresponding	abstract[30]|abstract[31]|abstract[32]|abstract[33]	new[30]|new[31]|new[32]|new[33]	coref	8-21[65_33]
4-13	699-706	changes	abstract[30]|abstract[31]|abstract[32]|abstract[33]	new[30]|new[31]|new[32]|new[33]	_	_
4-14	707-709	in	abstract[30]|abstract[31]|abstract[32]|abstract[33]	new[30]|new[31]|new[32]|new[33]	_	_
4-15	710-713	the	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]	new[30]|new[31]|new[32]|new[33]|new[34]	_	_
4-16	714-724	biological	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]	new[30]|new[31]|new[32]|new[33]|new[34]	_	_
4-17	725-734	responses	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]	new[30]|new[31]|new[32]|new[33]|new[34]	_	_
4-18	735-738	for	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]	new[30]|new[31]|new[32]|new[33]|new[34]	_	_
4-19	739-740	a	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]|abstract[35]	new[30]|new[31]|new[32]|new[33]|new[34]|new[35]	_	_
4-20	741-751	congeneric	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]|abstract[35]	new[30]|new[31]|new[32]|new[33]|new[34]|new[35]	_	_
4-21	752-758	series	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]|abstract[35]	new[30]|new[31]|new[32]|new[33]|new[34]|new[35]	_	_
4-22	759-761	of	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]|abstract[35]	new[30]|new[31]|new[32]|new[33]|new[34]|new[35]	_	_
4-23	762-771	molecules	abstract[30]|abstract[31]|abstract[32]|abstract[33]|abstract[34]|abstract[35]|substance	new[30]|new[31]|new[32]|new[33]|new[34]|new[35]|new	coref	9-12[69_0]
4-24	772-775	are	_	_	_	_
4-25	776-787	fundamental	_	_	_	_
4-26	788-791	for	_	_	_	_
4-27	792-795	the	abstract[40]	new[40]	_	_
4-28	796-812	multidimensional	abstract[40]	new[40]	_	_
4-29	813-825	quantitative	abstract[37]|abstract[40]	new[37]|new[40]	appos	4-34[0_37]
4-30	826-835	structure	abstract[37]|abstract[40]	new[37]|new[40]	_	_
4-31	836-837	–	abstract[37]|abstract[40]	new[37]|new[40]	_	_
4-32	838-846	activity	abstract[37]|abstract|abstract[40]	new[37]|new|new[40]	coref	7-6
4-33	847-848	(	abstract[40]	new[40]	_	_
4-34	849-856	mD-QSAR	abstract|abstract[40]	giv|new[40]	coref	7-4
4-35	857-858	)	abstract[40]	new[40]	_	_
4-36	859-866	studies	abstract[40]	new[40]	_	_
4-37	867-868	.	_	_	_	_

#Text=Moving from complex biological relationships to simple QSAR models seems to be a ‘ triumph of hope over experience , ’ since modelers sometimes are playing a ‘ glass bead game . ’
5-1	869-875	Moving	_	_	_	_
5-2	876-880	from	_	_	_	_
5-3	881-888	complex	abstract[41]	new[41]	_	_
5-4	889-899	biological	abstract[41]	new[41]	_	_
5-5	900-913	relationships	abstract[41]	new[41]	_	_
5-6	914-916	to	_	_	_	_
5-7	917-923	simple	abstract[43]	new[43]	coref	23-11[230_43]
5-8	924-928	QSAR	abstract|abstract[43]	new|new[43]	coref	9-9
5-9	929-935	models	abstract[43]	new[43]	_	_
5-10	936-941	seems	_	_	_	_
5-11	942-944	to	_	_	_	_
5-12	945-947	be	_	_	_	_
5-13	948-949	a	event[44]	new[44]	_	_
5-14	950-951	‘	event[44]	new[44]	_	_
5-15	952-959	triumph	event[44]	new[44]	_	_
5-16	960-962	of	event[44]	new[44]	_	_
5-17	963-967	hope	event[44]|abstract	new[44]|new	_	_
5-18	968-972	over	event[44]	new[44]	_	_
5-19	973-983	experience	event[44]|abstract	new[44]|new	_	_
5-20	984-985	,	_	_	_	_
5-21	986-987	’	_	_	_	_
5-22	988-993	since	_	_	_	_
5-23	994-1002	modelers	person	new	_	_
5-24	1003-1012	sometimes	_	_	_	_
5-25	1013-1016	are	_	_	_	_
5-26	1017-1024	playing	_	_	_	_
5-27	1025-1026	a	abstract[50]	new[50]	_	_
5-28	1027-1028	‘	abstract[50]	new[50]	_	_
5-29	1029-1034	glass	object|abstract[50]	new|new[50]	_	_
5-30	1035-1039	bead	object|abstract[50]	new|new[50]	_	_
5-31	1040-1044	game	abstract[50]	new[50]	_	_
5-32	1045-1046	.	_	_	_	_
5-33	1047-1048	’	_	_	_	_

#Text=The quantitative mapping of experimental/calculated properties/descriptors into the ADMET-driven molecular potency is frequently a ‘ hit-or-miss affair . ’
6-1	1049-1052	The	abstract[51]	new[51]	coref	6-13[54_51]
6-2	1053-1065	quantitative	abstract[51]	new[51]	_	_
6-3	1066-1073	mapping	abstract[51]	new[51]	_	_
6-4	1074-1076	of	abstract[51]	new[51]	_	_
6-5	1077-1100	experimental/calculated	abstract[51]|abstract[52]	new[51]|new[52]	_	_
6-6	1101-1123	properties/descriptors	abstract[51]|abstract[52]	new[51]|new[52]	_	_
6-7	1124-1128	into	abstract[51]	new[51]	_	_
6-8	1129-1132	the	abstract[51]|abstract[53]	new[51]|new[53]	coref	17-37[0_53]
6-9	1133-1145	ADMET-driven	abstract[51]|abstract[53]	new[51]|new[53]	_	_
6-10	1146-1155	molecular	abstract[51]|abstract[53]	new[51]|new[53]	_	_
6-11	1156-1163	potency	abstract[51]|abstract[53]	new[51]|new[53]	_	_
6-12	1164-1166	is	_	_	_	_
6-13	1167-1177	frequently	abstract[54]	giv[54]	_	_
6-14	1178-1179	a	abstract[54]	giv[54]	_	_
6-15	1180-1181	‘	abstract[54]	giv[54]	_	_
6-16	1182-1193	hit-or-miss	abstract[54]	giv[54]	_	_
6-17	1194-1200	affair	abstract[54]	giv[54]	_	_
6-18	1201-1202	.	_	_	_	_
6-19	1203-1204	’	_	_	_	_

#Text=Therefore , some structure – activity relationship ( SAR)-mediated guides are urgently needed at the ‘ pre-synthesis ’ stage .
7-1	1205-1214	Therefore	_	_	_	_
7-2	1215-1216	,	_	_	_	_
7-3	1217-1221	some	object[58]	new[58]	_	_
7-4	1222-1231	structure	abstract|object[58]	giv|new[58]	coref	8-18
7-5	1232-1233	–	object[58]	new[58]	_	_
7-6	1234-1242	activity	abstract|abstract[57]|object[58]	giv|new[57]|new[58]	coref	8-24
7-7	1243-1255	relationship	abstract[57]|object[58]	new[57]|new[58]	_	_
7-8	1256-1257	(	abstract[57]|object[58]	new[57]|new[58]	_	_
7-9	1258-1271	SAR)-mediated	abstract[57]|object[58]	new[57]|new[58]	_	_
7-10	1272-1278	guides	object[58]	new[58]	_	_
7-11	1279-1282	are	_	_	_	_
7-12	1283-1291	urgently	_	_	_	_
7-13	1292-1298	needed	_	_	_	_
7-14	1299-1301	at	_	_	_	_
7-15	1302-1305	the	abstract[59]	new[59]	_	_
7-16	1306-1307	‘	abstract[59]	new[59]	_	_
7-17	1308-1321	pre-synthesis	abstract[59]	new[59]	_	_
7-18	1322-1323	’	abstract[59]	new[59]	_	_
7-19	1324-1329	stage	abstract[59]	new[59]	_	_
7-20	1330-1331	.	_	_	_	_

#Text=Molecular similarity is unarguably at the core of many SAR-based methods , assuming that small variations in structure lead to small changes in activity .
8-1	1332-1341	Molecular	abstract[60]	new[60]	coref	9-14[70_60]
8-2	1342-1352	similarity	abstract[60]	new[60]	_	_
8-3	1353-1355	is	_	_	_	_
8-4	1356-1366	unarguably	_	_	_	_
8-5	1367-1369	at	_	_	_	_
8-6	1370-1373	the	abstract[61]	new[61]	_	_
8-7	1374-1378	core	abstract[61]	new[61]	_	_
8-8	1379-1381	of	abstract[61]	new[61]	_	_
8-9	1382-1386	many	abstract[61]|abstract[62]	new[61]|new[62]	coref	15-22[137_62]
8-10	1387-1396	SAR-based	abstract[61]|abstract[62]	new[61]|new[62]	_	_
8-11	1397-1404	methods	abstract[61]|abstract[62]	new[61]|new[62]	_	_
8-12	1405-1406	,	abstract[61]	new[61]	_	_
8-13	1407-1415	assuming	abstract[61]	new[61]	_	_
8-14	1416-1420	that	abstract[61]	new[61]	_	_
8-15	1421-1426	small	abstract[61]|abstract[63]	new[61]|new[63]	coref	21-9[208_63]
8-16	1427-1437	variations	abstract[61]|abstract[63]	new[61]|new[63]	_	_
8-17	1438-1440	in	abstract[61]|abstract[63]	new[61]|new[63]	_	_
8-18	1441-1450	structure	abstract[61]|abstract[63]|abstract	new[61]|new[63]|giv	coref	19-7
8-19	1451-1455	lead	abstract[61]	new[61]	_	_
8-20	1456-1458	to	_	_	_	_
8-21	1459-1464	small	abstract[65]	giv[65]	coref	17-19[159_65]
8-22	1465-1472	changes	abstract[65]	giv[65]	_	_
8-23	1473-1475	in	abstract[65]	giv[65]	_	_
8-24	1476-1484	activity	abstract[65]|abstract	giv[65]|giv	coref	17-59
8-25	1485-1486	.	_	_	_	_

#Text=In other words , the working tenet of QSAR is that molecules with high similarity share common effects ( similarity principle ) ; however , the validity of the assumption is still questionable — there is no absolute standard ( or metric ) of similarity .
9-1	1487-1489	In	_	_	_	_
9-2	1490-1495	other	_	_	_	_
9-3	1496-1501	words	_	_	_	_
9-4	1502-1503	,	_	_	_	_
9-5	1504-1507	the	abstract[67]	new[67]	_	_
9-6	1508-1515	working	abstract[67]	new[67]	_	_
9-7	1516-1521	tenet	abstract[67]	new[67]	_	_
9-8	1522-1524	of	abstract[67]	new[67]	_	_
9-9	1525-1529	QSAR	abstract[67]|abstract	new[67]|giv	_	_
9-10	1530-1532	is	_	_	_	_
9-11	1533-1537	that	_	_	_	_
9-12	1538-1547	molecules	substance[69]	giv[69]	coref	21-48[218_69]
9-13	1548-1552	with	substance[69]	giv[69]	_	_
9-14	1553-1557	high	substance[69]|abstract[70]	giv[69]|giv[70]	coref	9-20[0_70]
9-15	1558-1568	similarity	substance[69]|abstract[70]	giv[69]|giv[70]	_	_
9-16	1569-1574	share	_	_	_	_
9-17	1575-1581	common	abstract[71]	new[71]	appos	9-20[73_71]
9-18	1582-1589	effects	abstract[71]	new[71]	_	_
9-19	1590-1591	(	_	_	_	_
9-20	1592-1602	similarity	abstract|abstract[73]	giv|giv[73]	coref	9-45
9-21	1603-1612	principle	abstract[73]	giv[73]	_	_
9-22	1613-1614	)	_	_	_	_
9-23	1615-1616	;	_	_	_	_
9-24	1617-1624	however	_	_	_	_
9-25	1625-1626	,	_	_	_	_
9-26	1627-1630	the	abstract[74]	new[74]	_	_
9-27	1631-1639	validity	abstract[74]	new[74]	_	_
9-28	1640-1642	of	abstract[74]	new[74]	_	_
9-29	1643-1646	the	abstract[74]|abstract[75]	new[74]|new[75]	_	_
9-30	1647-1657	assumption	abstract[74]|abstract[75]	new[74]|new[75]	_	_
9-31	1658-1660	is	_	_	_	_
9-32	1661-1666	still	_	_	_	_
9-33	1667-1679	questionable	_	_	_	_
9-34	1680-1681	—	_	_	_	_
9-35	1682-1687	there	_	_	_	_
9-36	1688-1690	is	_	_	_	_
9-37	1691-1693	no	abstract[76]	new[76]	_	_
9-38	1694-1702	absolute	abstract[76]	new[76]	_	_
9-39	1703-1711	standard	abstract[76]	new[76]	_	_
9-40	1712-1713	(	_	_	_	_
9-41	1714-1716	or	_	_	_	_
9-42	1717-1723	metric	abstract[77]	new[77]	_	_
9-43	1724-1725	)	abstract[77]	new[77]	_	_
9-44	1726-1728	of	abstract[77]	new[77]	_	_
9-45	1729-1739	similarity	abstract[77]|abstract	new[77]|giv	coref	10-4
9-46	1740-1741	.	_	_	_	_

#Text=In fact , similarity is a subjective concept directly related to aspects of human cognition ; this phenomena is sometimes called ‘ psychological proximity ’ .
10-1	1742-1744	In	_	_	_	_
10-2	1745-1749	fact	_	_	_	_
10-3	1750-1751	,	_	_	_	_
10-4	1752-1762	similarity	abstract	giv	coref	10-6[80_0]
10-5	1763-1765	is	_	_	_	_
10-6	1766-1767	a	abstract[80]	giv[80]	coref	11-8[87_80]
10-7	1768-1778	subjective	abstract[80]	giv[80]	_	_
10-8	1779-1786	concept	abstract[80]	giv[80]	_	_
10-9	1787-1795	directly	abstract[80]	giv[80]	_	_
10-10	1796-1803	related	abstract[80]	giv[80]	_	_
10-11	1804-1806	to	abstract[80]	giv[80]	_	_
10-12	1807-1814	aspects	abstract[80]|abstract[81]	giv[80]|new[81]	_	_
10-13	1815-1817	of	abstract[80]|abstract[81]	giv[80]|new[81]	_	_
10-14	1818-1823	human	abstract[80]|abstract[81]|abstract[82]	giv[80]|new[81]|new[82]	_	_
10-15	1824-1833	cognition	abstract[80]|abstract[81]|abstract[82]	giv[80]|new[81]|new[82]	_	_
10-16	1834-1835	;	_	_	_	_
10-17	1836-1840	this	abstract[83]	new[83]	_	_
10-18	1841-1850	phenomena	abstract[83]	new[83]	_	_
10-19	1851-1853	is	_	_	_	_
10-20	1854-1863	sometimes	_	_	_	_
10-21	1864-1870	called	_	_	_	_
10-22	1871-1872	‘	_	_	_	_
10-23	1873-1886	psychological	abstract[84]	new[84]	_	_
10-24	1887-1896	proximity	abstract[84]	new[84]	_	_
10-25	1897-1898	’	_	_	_	_
10-26	1899-1900	.	_	_	_	_

#Text=Maggiora ’s provocative statement that , “ Similarity , like pornography , is difficult to define , but you know it when you see it , ” is probably a better illustration of cognitive aspects of similarity .
11-1	1901-1909	Maggiora	person[85]|abstract[86]	new[85]|new[86]	ana	11-21[0_86]
11-2	1910-1912	’s	person[85]|abstract[86]	new[85]|new[86]	_	_
11-3	1913-1924	provocative	abstract[86]	new[86]	_	_
11-4	1925-1934	statement	abstract[86]	new[86]	_	_
11-5	1935-1939	that	abstract[86]	new[86]	_	_
11-6	1940-1941	,	abstract[86]	new[86]	_	_
11-7	1942-1943	“	abstract[86]	new[86]	_	_
11-8	1944-1954	Similarity	abstract[86]|abstract[87]	new[86]|giv[87]	coref	11-37[0_87]
11-9	1955-1956	,	abstract[86]|abstract[87]	new[86]|giv[87]	_	_
11-10	1957-1961	like	abstract[86]|abstract[87]	new[86]|giv[87]	_	_
11-11	1962-1973	pornography	abstract[86]|abstract[87]|abstract	new[86]|giv[87]|new	_	_
11-12	1974-1975	,	abstract[86]	new[86]	_	_
11-13	1976-1978	is	abstract[86]	new[86]	_	_
11-14	1979-1988	difficult	abstract[86]	new[86]	_	_
11-15	1989-1991	to	abstract[86]	new[86]	_	_
11-16	1992-1998	define	abstract[86]	new[86]	_	_
11-17	1999-2000	,	abstract[86]	new[86]	_	_
11-18	2001-2004	but	abstract[86]	new[86]	_	_
11-19	2005-2008	you	abstract[86]|person	new[86]|acc	ana	11-23
11-20	2009-2013	know	abstract[86]	new[86]	_	_
11-21	2014-2016	it	abstract[86]|abstract	new[86]|giv	ana	11-25
11-22	2017-2021	when	_	_	_	_
11-23	2022-2025	you	person	giv	_	_
11-24	2026-2029	see	_	_	_	_
11-25	2030-2032	it	abstract	giv	coref	11-29[93_0]
11-26	2033-2034	,	_	_	_	_
11-27	2035-2036	”	_	_	_	_
11-28	2037-2039	is	_	_	_	_
11-29	2040-2048	probably	abstract[93]	giv[93]	_	_
11-30	2049-2050	a	abstract[93]	giv[93]	_	_
11-31	2051-2057	better	abstract[93]	giv[93]	_	_
11-32	2058-2070	illustration	abstract[93]	giv[93]	_	_
11-33	2071-2073	of	abstract[93]	giv[93]	_	_
11-34	2074-2083	cognitive	abstract[93]|abstract[94]	giv[93]|new[94]	_	_
11-35	2084-2091	aspects	abstract[93]|abstract[94]	giv[93]|new[94]	_	_
11-36	2092-2094	of	abstract[93]|abstract[94]	giv[93]|new[94]	_	_
11-37	2095-2105	similarity	abstract[93]|abstract[94]|abstract	giv[93]|new[94]|giv	coref	12-12
11-38	2106-2107	.	_	_	_	_

#Text=Despite the presence of fluid scientific boundaries , e.g. , some similarity metrics exhibit size-dependent behavior — similarity quantification is still a powerful concept that allows us to specify ( with some confidence ) the shared host – quest interactions .
12-1	2108-2115	Despite	_	_	_	_
12-2	2116-2119	the	abstract[96]	new[96]	_	_
12-3	2120-2128	presence	abstract[96]	new[96]	_	_
12-4	2129-2131	of	abstract[96]	new[96]	_	_
12-5	2132-2137	fluid	abstract[96]|abstract[97]	new[96]|new[97]	_	_
12-6	2138-2148	scientific	abstract[96]|abstract[97]	new[96]|new[97]	_	_
12-7	2149-2159	boundaries	abstract[96]|abstract[97]	new[96]|new[97]	_	_
12-8	2160-2161	,	_	_	_	_
12-9	2162-2166	e.g.	_	_	_	_
12-10	2167-2168	,	_	_	_	_
12-11	2169-2173	some	abstract[99]	new[99]	coref	25-17[249_99]
12-12	2174-2184	similarity	abstract|abstract[99]	giv|new[99]	coref	12-18
12-13	2185-2192	metrics	abstract[99]	new[99]	_	_
12-14	2193-2200	exhibit	_	_	_	_
12-15	2201-2215	size-dependent	abstract[100]	new[100]	_	_
12-16	2216-2224	behavior	abstract[100]	new[100]	_	_
12-17	2225-2226	—	_	_	_	_
12-18	2227-2237	similarity	abstract|abstract[102]	giv|new[102]	coref|coref	12-21[103_102]|13-12[111_0]
12-19	2238-2252	quantification	abstract[102]	new[102]	_	_
12-20	2253-2255	is	_	_	_	_
12-21	2256-2261	still	abstract[103]	giv[103]	coref	25-1[242_103]
12-22	2262-2263	a	abstract[103]	giv[103]	_	_
12-23	2264-2272	powerful	abstract[103]	giv[103]	_	_
12-24	2273-2280	concept	abstract[103]	giv[103]	_	_
12-25	2281-2285	that	abstract[103]	giv[103]	_	_
12-26	2286-2292	allows	abstract[103]	giv[103]	_	_
12-27	2293-2295	us	abstract[103]|person	giv[103]|acc	ana	19-3
12-28	2296-2298	to	abstract[103]	giv[103]	_	_
12-29	2299-2306	specify	abstract[103]	giv[103]	_	_
12-30	2307-2308	(	abstract[103]	giv[103]	_	_
12-31	2309-2313	with	abstract[103]	giv[103]	_	_
12-32	2314-2318	some	abstract[103]|abstract[105]	giv[103]|new[105]	_	_
12-33	2319-2329	confidence	abstract[103]|abstract[105]	giv[103]|new[105]	_	_
12-34	2330-2331	)	abstract[103]	giv[103]	_	_
12-35	2332-2335	the	abstract[103]|abstract[108]	giv[103]|new[108]	_	_
12-36	2336-2342	shared	abstract[103]|person[106]|abstract[108]	giv[103]|new[106]|new[108]	_	_
12-37	2343-2347	host	abstract[103]|person[106]|abstract[108]	giv[103]|new[106]|new[108]	_	_
12-38	2348-2349	–	abstract[103]|person[106]|abstract[108]	giv[103]|new[106]|new[108]	_	_
12-39	2350-2355	quest	abstract[103]|person[106]|event|abstract[108]	giv[103]|new[106]|new|new[108]	coref	17-10[158_0]
12-40	2356-2368	interactions	abstract[103]|abstract[108]	giv[103]|new[108]	_	_
12-41	2369-2370	.	_	_	_	_

#Text=In fact , the idea of specifying a numerical measure of the intermolecular similarity based on the degree of the resemblance between two objects , each described by a number of attributes , has been widely applied in chemical information systems .
13-1	2371-2373	In	_	_	_	_
13-2	2374-2378	fact	_	_	_	_
13-3	2379-2380	,	_	_	_	_
13-4	2381-2384	the	abstract[109]	new[109]	_	_
13-5	2385-2389	idea	abstract[109]	new[109]	_	_
13-6	2390-2392	of	abstract[109]	new[109]	_	_
13-7	2393-2403	specifying	abstract[109]	new[109]	_	_
13-8	2404-2405	a	abstract[109]|abstract[110]	new[109]|new[110]	_	_
13-9	2406-2415	numerical	abstract[109]|abstract[110]	new[109]|new[110]	_	_
13-10	2416-2423	measure	abstract[109]|abstract[110]	new[109]|new[110]	_	_
13-11	2424-2426	of	abstract[109]|abstract[110]	new[109]|new[110]	_	_
13-12	2427-2430	the	abstract[109]|abstract[110]|abstract[111]	new[109]|new[110]|giv[111]	coref	15-51[0_111]
13-13	2431-2445	intermolecular	abstract[109]|abstract[110]|abstract[111]	new[109]|new[110]|giv[111]	_	_
13-14	2446-2456	similarity	abstract[109]|abstract[110]|abstract[111]	new[109]|new[110]|giv[111]	_	_
13-15	2457-2462	based	abstract[109]|abstract[110]|abstract[111]	new[109]|new[110]|giv[111]	_	_
13-16	2463-2465	on	abstract[109]|abstract[110]|abstract[111]	new[109]|new[110]|giv[111]	_	_
13-17	2466-2469	the	abstract[109]|abstract[110]|abstract[111]|abstract[112]	new[109]|new[110]|giv[111]|new[112]	_	_
13-18	2470-2476	degree	abstract[109]|abstract[110]|abstract[111]|abstract[112]	new[109]|new[110]|giv[111]|new[112]	_	_
13-19	2477-2479	of	abstract[109]|abstract[110]|abstract[111]|abstract[112]	new[109]|new[110]|giv[111]|new[112]	_	_
13-20	2480-2483	the	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]	new[109]|new[110]|giv[111]|new[112]|new[113]	coref	14-33[126_113]
13-21	2484-2495	resemblance	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]	new[109]|new[110]|giv[111]|new[112]|new[113]	_	_
13-22	2496-2503	between	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]	new[109]|new[110]|giv[111]|new[112]|new[113]	_	_
13-23	2504-2507	two	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]	coref	14-37[0_114]
13-24	2508-2515	objects	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]	_	_
13-25	2516-2517	,	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]	_	_
13-26	2518-2522	each	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]	_	_
13-27	2523-2532	described	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]	_	_
13-28	2533-2535	by	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]	_	_
13-29	2536-2537	a	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]|abstract[115]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]|new[115]	_	_
13-30	2538-2544	number	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]|abstract[115]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]|new[115]	_	_
13-31	2545-2547	of	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]|abstract[115]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]|new[115]	_	_
13-32	2548-2558	attributes	abstract[109]|abstract[110]|abstract[111]|abstract[112]|abstract[113]|object[114]|abstract[115]	new[109]|new[110]|giv[111]|new[112]|new[113]|new[114]|new[115]	_	_
13-33	2559-2560	,	_	_	_	_
13-34	2561-2564	has	_	_	_	_
13-35	2565-2569	been	_	_	_	_
13-36	2570-2576	widely	_	_	_	_
13-37	2577-2584	applied	_	_	_	_
13-38	2585-2587	in	_	_	_	_
13-39	2588-2596	chemical	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-40	2597-2608	information	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-41	2609-2616	systems	abstract[117]	new[117]	_	_
13-42	2617-2618	.	_	_	_	_

#Text=A set of characteristics might be denoted by a bit-string representation , sometimes augmented with the weighting factors , assigning varying importance to the particular descriptors to calculate a quantitative measure of the structural resemblance between objects , for instance Tanimoto coefficient .
14-1	2619-2620	A	abstract[118]	new[118]	_	_
14-2	2621-2624	set	abstract[118]	new[118]	_	_
14-3	2625-2627	of	abstract[118]	new[118]	_	_
14-4	2628-2643	characteristics	abstract[118]	new[118]	_	_
14-5	2644-2649	might	_	_	_	_
14-6	2650-2652	be	_	_	_	_
14-7	2653-2660	denoted	_	_	_	_
14-8	2661-2663	by	_	_	_	_
14-9	2664-2665	a	abstract[120]	new[120]	_	_
14-10	2666-2676	bit-string	object|abstract[120]	new|new[120]	_	_
14-11	2677-2691	representation	abstract[120]	new[120]	_	_
14-12	2692-2693	,	abstract[120]	new[120]	_	_
14-13	2694-2703	sometimes	abstract[120]	new[120]	_	_
14-14	2704-2713	augmented	abstract[120]	new[120]	_	_
14-15	2714-2718	with	abstract[120]	new[120]	_	_
14-16	2719-2722	the	abstract[120]|abstract[122]	new[120]|new[122]	_	_
14-17	2723-2732	weighting	abstract[120]|abstract|abstract[122]	new[120]|new|new[122]	_	_
14-18	2733-2740	factors	abstract[120]|abstract[122]	new[120]|new[122]	_	_
14-19	2741-2742	,	_	_	_	_
14-20	2743-2752	assigning	_	_	_	_
14-21	2753-2760	varying	abstract[123]	new[123]	_	_
14-22	2761-2771	importance	abstract[123]	new[123]	_	_
14-23	2772-2774	to	_	_	_	_
14-24	2775-2778	the	abstract[124]	giv[124]	coref	15-14[133_124]
14-25	2779-2789	particular	abstract[124]	giv[124]	_	_
14-26	2790-2801	descriptors	abstract[124]	giv[124]	_	_
14-27	2802-2804	to	_	_	_	_
14-28	2805-2814	calculate	_	_	_	_
14-29	2815-2816	a	abstract[125]	new[125]	_	_
14-30	2817-2829	quantitative	abstract[125]	new[125]	_	_
14-31	2830-2837	measure	abstract[125]	new[125]	_	_
14-32	2838-2840	of	abstract[125]	new[125]	_	_
14-33	2841-2844	the	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
14-34	2845-2855	structural	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
14-35	2856-2867	resemblance	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
14-36	2868-2875	between	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
14-37	2876-2883	objects	abstract[125]|abstract[126]|object	new[125]|giv[126]|giv	_	_
14-38	2884-2885	,	abstract[125]	new[125]	_	_
14-39	2886-2889	for	abstract[125]	new[125]	_	_
14-40	2890-2898	instance	abstract[125]	new[125]	_	_
14-41	2899-2907	Tanimoto	abstract[125]|object|abstract[129]	new[125]|new|new[129]	_	_
14-42	2908-2919	coefficient	abstract[125]|abstract[129]	new[125]|new[129]	_	_
14-43	2920-2921	.	_	_	_	_

#Text=Obviously , a crucial question that confronts drug ‘ hunters ’ is , which properties or features should be employed in the receptor-dependent ( RD ) methods that rely on the principle of complementarity or in the receptor-independent ( RI ) ones that are mainly based on the principle of similarity ?
15-1	2922-2931	Obviously	_	_	_	_
15-2	2932-2933	,	_	_	_	_
15-3	2934-2935	a	abstract[130]	new[130]	coref	24-11[235_130]
15-4	2936-2943	crucial	abstract[130]	new[130]	_	_
15-5	2944-2952	question	abstract[130]	new[130]	_	_
15-6	2953-2957	that	abstract[130]	new[130]	_	_
15-7	2958-2967	confronts	abstract[130]	new[130]	_	_
15-8	2968-2972	drug	abstract[130]|substance|person[132]	new[130]|giv|new[132]	coref	16-46
15-9	2973-2974	‘	abstract[130]|person[132]	new[130]|new[132]	_	_
15-10	2975-2982	hunters	abstract[130]|person[132]	new[130]|new[132]	_	_
15-11	2983-2984	’	abstract[130]|person[132]	new[130]|new[132]	_	_
15-12	2985-2987	is	_	_	_	_
15-13	2988-2989	,	_	_	_	_
15-14	2990-2995	which	abstract[133]|abstract[134]	giv[133]|giv[134]	coref|coref	15-14[134_133]|18-10[175_134]
15-15	2996-3006	properties	abstract[133]|abstract[134]	giv[133]|giv[134]	_	_
15-16	3007-3009	or	abstract[134]	giv[134]	_	_
15-17	3010-3018	features	abstract[134]|abstract	giv[134]|new	_	_
15-18	3019-3025	should	_	_	_	_
15-19	3026-3028	be	_	_	_	_
15-20	3029-3037	employed	_	_	_	_
15-21	3038-3040	in	_	_	_	_
15-22	3041-3044	the	abstract[137]	giv[137]	_	_
15-23	3045-3063	receptor-dependent	abstract[137]	giv[137]	_	_
15-24	3064-3065	(	abstract[137]	giv[137]	_	_
15-25	3066-3068	RD	abstract|abstract[137]	new|giv[137]	_	_
15-26	3069-3070	)	abstract[137]	giv[137]	_	_
15-27	3071-3078	methods	abstract[137]	giv[137]	_	_
15-28	3079-3083	that	abstract[137]	giv[137]	_	_
15-29	3084-3088	rely	abstract[137]	giv[137]	_	_
15-30	3089-3091	on	abstract[137]	giv[137]	_	_
15-31	3092-3095	the	abstract[137]|abstract[138]	giv[137]|new[138]	_	_
15-32	3096-3105	principle	abstract[137]|abstract[138]	giv[137]|new[138]	_	_
15-33	3106-3108	of	abstract[137]|abstract[138]	giv[137]|new[138]	_	_
15-34	3109-3124	complementarity	abstract[137]|abstract[138]|abstract	giv[137]|new[138]|new	_	_
15-35	3125-3127	or	_	_	_	_
15-36	3128-3130	in	_	_	_	_
15-37	3131-3134	the	abstract[141]	new[141]	_	_
15-38	3135-3155	receptor-independent	abstract[141]	new[141]	_	_
15-39	3156-3157	(	abstract[141]	new[141]	_	_
15-40	3158-3160	RI	abstract|abstract[141]	new|new[141]	_	_
15-41	3161-3162	)	abstract[141]	new[141]	_	_
15-42	3163-3167	ones	abstract[141]	new[141]	_	_
15-43	3168-3172	that	abstract[141]	new[141]	_	_
15-44	3173-3176	are	abstract[141]	new[141]	_	_
15-45	3177-3183	mainly	abstract[141]	new[141]	_	_
15-46	3184-3189	based	abstract[141]	new[141]	_	_
15-47	3190-3192	on	abstract[141]	new[141]	_	_
15-48	3193-3196	the	abstract[141]|abstract[142]	new[141]|new[142]	_	_
15-49	3197-3206	principle	abstract[141]|abstract[142]	new[141]|new[142]	_	_
15-50	3207-3209	of	abstract[141]|abstract[142]	new[141]|new[142]	_	_
15-51	3210-3220	similarity	abstract[141]|abstract[142]|abstract	new[141]|new[142]|giv	coref	25-17
15-52	3221-3222	?	_	_	_	_

#Text=Hence , many attempts have been undertaken in order to implement some rough guidelines , sometimes called ‘ rules of thumb ’ for both the ligand and structure-based in silico protocols ; however , even meeting the rules does not guarantee the final success of drug discovery projects .
16-1	3223-3228	Hence	_	_	_	_
16-2	3229-3230	,	_	_	_	_
16-3	3231-3235	many	event[144]	new[144]	_	_
16-4	3236-3244	attempts	event[144]	new[144]	_	_
16-5	3245-3249	have	_	_	_	_
16-6	3250-3254	been	_	_	_	_
16-7	3255-3265	undertaken	_	_	_	_
16-8	3266-3268	in	_	_	_	_
16-9	3269-3274	order	_	_	_	_
16-10	3275-3277	to	_	_	_	_
16-11	3278-3287	implement	_	_	_	_
16-12	3288-3292	some	abstract[145]	new[145]	_	_
16-13	3293-3298	rough	abstract[145]	new[145]	_	_
16-14	3299-3309	guidelines	abstract[145]	new[145]	_	_
16-15	3310-3311	,	abstract[145]	new[145]	_	_
16-16	3312-3321	sometimes	abstract[145]	new[145]	_	_
16-17	3322-3328	called	abstract[145]	new[145]	_	_
16-18	3329-3330	‘	abstract[145]	new[145]	_	_
16-19	3331-3336	rules	abstract[145]|abstract[146]	new[145]|new[146]	coref	16-37[150_146]
16-20	3337-3339	of	abstract[145]|abstract[146]	new[145]|new[146]	_	_
16-21	3340-3345	thumb	abstract[145]|abstract[146]	new[145]|new[146]	_	_
16-22	3346-3347	’	abstract[145]	new[145]	_	_
16-23	3348-3351	for	abstract[145]	new[145]	_	_
16-24	3352-3356	both	abstract[145]|substance[147]|abstract[149]	new[145]|new[147]|new[149]	_	_
16-25	3357-3360	the	abstract[145]|substance[147]|abstract[149]	new[145]|new[147]|new[149]	_	_
16-26	3361-3367	ligand	abstract[145]|substance[147]|abstract[149]	new[145]|new[147]|new[149]	_	_
16-27	3368-3371	and	abstract[145]|abstract[149]	new[145]|new[149]	_	_
16-28	3372-3387	structure-based	abstract[145]|abstract[149]	new[145]|new[149]	_	_
16-29	3388-3390	in	abstract[145]|abstract[149]	new[145]|new[149]	_	_
16-30	3391-3397	silico	abstract[145]|place|abstract[149]	new[145]|giv|new[149]	_	_
16-31	3398-3407	protocols	abstract[145]|abstract[149]	new[145]|new[149]	_	_
16-32	3408-3409	;	_	_	_	_
16-33	3410-3417	however	_	_	_	_
16-34	3418-3419	,	_	_	_	_
16-35	3420-3424	even	_	_	_	_
16-36	3425-3432	meeting	_	_	_	_
16-37	3433-3436	the	abstract[150]	giv[150]	_	_
16-38	3437-3442	rules	abstract[150]	giv[150]	_	_
16-39	3443-3447	does	_	_	_	_
16-40	3448-3451	not	_	_	_	_
16-41	3452-3461	guarantee	_	_	_	_
16-42	3462-3465	the	abstract[151]	new[151]	_	_
16-43	3466-3471	final	abstract[151]	new[151]	_	_
16-44	3472-3479	success	abstract[151]	new[151]	_	_
16-45	3480-3482	of	abstract[151]	new[151]	_	_
16-46	3483-3487	drug	abstract[151]|substance|abstract[153]|abstract[154]	new[151]|giv|giv[153]|giv[154]	coref	18-14
16-47	3488-3497	discovery	abstract[151]|abstract[153]|abstract[154]	new[151]|giv[153]|giv[154]	_	_
16-48	3498-3506	projects	abstract[151]|abstract[154]	new[151]|giv[154]	_	_
16-49	3507-3508	.	_	_	_	_

#Text=A confusing aspect of many SAR analyses is that the ‘ fragile event ’ can occur , when even small structural changes ( colloquially termed ‘ magic methyl ’ ) can result in a boost of potency for the target , or in a more detrimental manner , can completely destroy biological response — a phenomenon known as activity ‘ hotspot ’ or activity ‘ cliff ’ in structure-activity landscape .
17-1	3509-3510	A	abstract[155]	new[155]	_	_
17-2	3511-3520	confusing	abstract[155]	new[155]	_	_
17-3	3521-3527	aspect	abstract[155]	new[155]	_	_
17-4	3528-3530	of	abstract[155]	new[155]	_	_
17-5	3531-3535	many	abstract[155]|abstract[157]	new[155]|new[157]	_	_
17-6	3536-3539	SAR	abstract[155]|abstract|abstract[157]	new[155]|new|new[157]	coref	18-47
17-7	3540-3548	analyses	abstract[155]|abstract[157]	new[155]|new[157]	_	_
17-8	3549-3551	is	_	_	_	_
17-9	3552-3556	that	_	_	_	_
17-10	3557-3560	the	event[158]	giv[158]	_	_
17-11	3561-3562	‘	event[158]	giv[158]	_	_
17-12	3563-3570	fragile	event[158]	giv[158]	_	_
17-13	3571-3576	event	event[158]	giv[158]	_	_
17-14	3577-3578	’	event[158]	giv[158]	_	_
17-15	3579-3582	can	_	_	_	_
17-16	3583-3588	occur	_	_	_	_
17-17	3589-3590	,	_	_	_	_
17-18	3591-3595	when	_	_	_	_
17-19	3596-3600	even	abstract[159]	giv[159]	coref	21-15[209_159]
17-20	3601-3606	small	abstract[159]	giv[159]	_	_
17-21	3607-3617	structural	abstract[159]	giv[159]	_	_
17-22	3618-3625	changes	abstract[159]	giv[159]	_	_
17-23	3626-3627	(	abstract[159]	giv[159]	_	_
17-24	3628-3640	colloquially	abstract[159]	giv[159]	_	_
17-25	3641-3647	termed	abstract[159]	giv[159]	_	_
17-26	3648-3649	‘	abstract[159]	giv[159]	_	_
17-27	3650-3655	magic	abstract[159]|abstract|substance[161]	giv[159]|new|new[161]	_	_
17-28	3656-3662	methyl	abstract[159]|substance[161]	giv[159]|new[161]	_	_
17-29	3663-3664	’	abstract[159]	giv[159]	_	_
17-30	3665-3666	)	_	_	_	_
17-31	3667-3670	can	_	_	_	_
17-32	3671-3677	result	_	_	_	_
17-33	3678-3680	in	_	_	_	_
17-34	3681-3682	a	abstract[162]	new[162]	_	_
17-35	3683-3688	boost	abstract[162]	new[162]	_	_
17-36	3689-3691	of	abstract[162]	new[162]	_	_
17-37	3692-3699	potency	abstract[162]|abstract	new[162]|giv	coref	18-13[178_0]
17-38	3700-3703	for	abstract[162]	new[162]	_	_
17-39	3704-3707	the	abstract[162]|animal[164]	new[162]|new[164]	_	_
17-40	3708-3714	target	abstract[162]|animal[164]	new[162]|new[164]	_	_
17-41	3715-3716	,	_	_	_	_
17-42	3717-3719	or	_	_	_	_
17-43	3720-3722	in	_	_	_	_
17-44	3723-3724	a	abstract[165]	new[165]	_	_
17-45	3725-3729	more	abstract[165]	new[165]	_	_
17-46	3730-3741	detrimental	abstract[165]	new[165]	_	_
17-47	3742-3748	manner	abstract[165]	new[165]	_	_
17-48	3749-3750	,	_	_	_	_
17-49	3751-3754	can	_	_	_	_
17-50	3755-3765	completely	_	_	_	_
17-51	3766-3773	destroy	_	_	_	_
17-52	3774-3784	biological	abstract[166]	new[166]	appos	17-55[167_166]
17-53	3785-3793	response	abstract[166]	new[166]	_	_
17-54	3794-3795	—	_	_	_	_
17-55	3796-3797	a	abstract[167]	giv[167]	coref	18-43[0_167]
17-56	3798-3808	phenomenon	abstract[167]	giv[167]	_	_
17-57	3809-3814	known	abstract[167]	giv[167]	_	_
17-58	3815-3817	as	abstract[167]	giv[167]	_	_
17-59	3818-3826	activity	abstract[167]|abstract|place[169]	giv[167]|giv|new[169]	coref	17-64
17-60	3827-3828	‘	abstract[167]|place[169]	giv[167]|new[169]	_	_
17-61	3829-3836	hotspot	abstract[167]|place[169]	giv[167]|new[169]	_	_
17-62	3837-3838	’	abstract[167]|place[169]	giv[167]|new[169]	_	_
17-63	3839-3841	or	abstract[167]	giv[167]	_	_
17-64	3842-3850	activity	abstract[167]|abstract|object[171]	giv[167]|giv|new[171]	coref	18-34
17-65	3851-3852	‘	abstract[167]|object[171]	giv[167]|new[171]	_	_
17-66	3853-3858	cliff	abstract[167]|object[171]	giv[167]|new[171]	_	_
17-67	3859-3860	’	abstract[167]|object[171]	giv[167]|new[171]	_	_
17-68	3861-3863	in	abstract[167]|object[171]	giv[167]|new[171]	_	_
17-69	3864-3882	structure-activity	abstract[167]|object[171]|person|abstract[173]	giv[167]|new[171]|new|new[173]	coref	22-30[226_173]
17-70	3883-3892	landscape	abstract[167]|object[171]|abstract[173]	giv[167]|new[171]|new[173]	_	_
17-71	3893-3894	.	_	_	_	_

#Text=In other words , finding the optimal balance between ADMET-related properties and desired drug potency ( ‘ sweet spot ’ ) can be rationalized graphically by extension of the 2D similarity-based projection with activity data in the form of a ‘ biological response surface ’ or SAR landscapes .
18-1	3895-3897	In	_	_	_	_
18-2	3898-3903	other	_	_	_	_
18-3	3904-3909	words	_	_	_	_
18-4	3910-3911	,	_	_	_	_
18-5	3912-3919	finding	_	_	_	_
18-6	3920-3923	the	abstract[174]	new[174]	_	_
18-7	3924-3931	optimal	abstract[174]	new[174]	_	_
18-8	3932-3939	balance	abstract[174]	new[174]	_	_
18-9	3940-3947	between	abstract[174]	new[174]	_	_
18-10	3948-3961	ADMET-related	abstract[174]|abstract[175]|abstract[176]	new[174]|giv[175]|giv[176]	coref	18-10[176_175]
18-11	3962-3972	properties	abstract[174]|abstract[175]|abstract[176]	new[174]|giv[175]|giv[176]	_	_
18-12	3973-3976	and	abstract[174]|abstract[176]	new[174]|giv[176]	_	_
18-13	3977-3984	desired	abstract[174]|abstract[176]|abstract[178]	new[174]|giv[176]|giv[178]	_	_
18-14	3985-3989	drug	abstract[174]|abstract[176]|substance|abstract[178]	new[174]|giv[176]|giv|giv[178]	_	_
18-15	3990-3997	potency	abstract[174]|abstract[176]|abstract[178]	new[174]|giv[176]|giv[178]	_	_
18-16	3998-3999	(	_	_	_	_
18-17	4000-4001	‘	_	_	_	_
18-18	4002-4007	sweet	place[179]	new[179]	_	_
18-19	4008-4012	spot	place[179]	new[179]	_	_
18-20	4013-4014	’	_	_	_	_
18-21	4015-4016	)	_	_	_	_
18-22	4017-4020	can	_	_	_	_
18-23	4021-4023	be	_	_	_	_
18-24	4024-4036	rationalized	_	_	_	_
18-25	4037-4048	graphically	_	_	_	_
18-26	4049-4051	by	_	_	_	_
18-27	4052-4061	extension	abstract[180]	new[180]	_	_
18-28	4062-4064	of	abstract[180]	new[180]	_	_
18-29	4065-4068	the	abstract[180]|abstract[181]	new[180]|new[181]	_	_
18-30	4069-4071	2D	abstract[180]|abstract[181]	new[180]|new[181]	_	_
18-31	4072-4088	similarity-based	abstract[180]|abstract[181]	new[180]|new[181]	_	_
18-32	4089-4099	projection	abstract[180]|abstract[181]	new[180]|new[181]	_	_
18-33	4100-4104	with	abstract[180]|abstract[181]	new[180]|new[181]	_	_
18-34	4105-4113	activity	abstract[180]|abstract[181]|abstract|abstract[183]	new[180]|new[181]|giv|new[183]	coref|coref	19-9|21-26[213_183]
18-35	4114-4118	data	abstract[180]|abstract[181]|abstract[183]	new[180]|new[181]|new[183]	_	_
18-36	4119-4121	in	abstract[180]|abstract[181]|abstract[183]	new[180]|new[181]|new[183]	_	_
18-37	4122-4125	the	abstract[180]|abstract[181]|abstract[183]|abstract[184]	new[180]|new[181]|new[183]|new[184]	_	_
18-38	4126-4130	form	abstract[180]|abstract[181]|abstract[183]|abstract[184]	new[180]|new[181]|new[183]|new[184]	_	_
18-39	4131-4133	of	abstract[180]|abstract[181]|abstract[183]|abstract[184]	new[180]|new[181]|new[183]|new[184]	_	_
18-40	4134-4135	a	abstract[180]|abstract[181]|abstract[183]|abstract[184]|place[186]	new[180]|new[181]|new[183]|new[184]|new[186]	_	_
18-41	4136-4137	‘	abstract[180]|abstract[181]|abstract[183]|abstract[184]|place[186]	new[180]|new[181]|new[183]|new[184]|new[186]	_	_
18-42	4138-4148	biological	abstract[180]|abstract[181]|abstract[183]|abstract[184]|place[186]	new[180]|new[181]|new[183]|new[184]|new[186]	_	_
18-43	4149-4157	response	abstract[180]|abstract[181]|abstract[183]|abstract[184]|abstract|place[186]	new[180]|new[181]|new[183]|new[184]|giv|new[186]	coref	22-23
18-44	4158-4165	surface	abstract[180]|abstract[181]|abstract[183]|abstract[184]|place[186]	new[180]|new[181]|new[183]|new[184]|new[186]	_	_
18-45	4166-4167	’	abstract[180]|abstract[181]|abstract[183]|abstract[184]|place[186]	new[180]|new[181]|new[183]|new[184]|new[186]	_	_
18-46	4168-4170	or	abstract[180]|abstract[181]|abstract[183]|abstract[184]	new[180]|new[181]|new[183]|new[184]	_	_
18-47	4171-4174	SAR	abstract[180]|abstract[181]|abstract[183]|abstract[184]|abstract|abstract[188]	new[180]|new[181]|new[183]|new[184]|giv|new[188]	coref|coref	19-6[192_188]|21-23
18-48	4175-4185	landscapes	abstract[180]|abstract[181]|abstract[183]|abstract[184]|abstract[188]	new[180]|new[181]|new[183]|new[184]|new[188]	_	_
18-49	4186-4187	.	_	_	_	_

#Text=Intuitively , we feel that the structure – activity landscapes are heterogeneous in nature with unevenly distributed regions that are reminiscent of Tolkien ’s Misty Mountains with gently slopes , steep cliffs and stony bridges .
19-1	4188-4199	Intuitively	_	_	_	_
19-2	4200-4201	,	_	_	_	_
19-3	4202-4204	we	person	giv	_	_
19-4	4205-4209	feel	_	_	_	_
19-5	4210-4214	that	_	_	_	_
19-6	4215-4218	the	abstract[192]	giv[192]	coref	21-22[212_192]
19-7	4219-4228	structure	abstract|abstract[192]	giv|giv[192]	coref	21-36[216_0]
19-8	4229-4230	–	abstract[192]	giv[192]	_	_
19-9	4231-4239	activity	abstract|abstract[192]	giv|giv[192]	coref	21-18
19-10	4240-4250	landscapes	abstract[192]	giv[192]	_	_
19-11	4251-4254	are	_	_	_	_
19-12	4255-4268	heterogeneous	_	_	_	_
19-13	4269-4271	in	_	_	_	_
19-14	4272-4278	nature	abstract	new	_	_
19-15	4279-4283	with	_	_	_	_
19-16	4284-4292	unevenly	_	_	_	_
19-17	4293-4304	distributed	place[194]	new[194]	coref	20-14[203_194]
19-18	4305-4312	regions	place[194]	new[194]	_	_
19-19	4313-4317	that	place[194]	new[194]	_	_
19-20	4318-4321	are	place[194]	new[194]	_	_
19-21	4322-4333	reminiscent	place[194]	new[194]	_	_
19-22	4334-4336	of	place[194]	new[194]	_	_
19-23	4337-4344	Tolkien	place[194]|person[195]|place[196]	new[194]|new[195]|new[196]	_	_
19-24	4345-4347	’s	place[194]|person[195]|place[196]	new[194]|new[195]|new[196]	_	_
19-25	4348-4353	Misty	place[194]|place[196]	new[194]|new[196]	_	_
19-26	4354-4363	Mountains	place[194]|place[196]	new[194]|new[196]	_	_
19-27	4364-4368	with	place[194]|place[196]	new[194]|new[196]	_	_
19-28	4369-4375	gently	place[194]|place[196]|place[197]	new[194]|new[196]|new[197]	_	_
19-29	4376-4382	slopes	place[194]|place[196]|place[197]	new[194]|new[196]|new[197]	_	_
19-30	4383-4384	,	place[194]|place[196]	new[194]|new[196]	_	_
19-31	4385-4390	steep	place[194]|place[196]|object[198]	new[194]|new[196]|new[198]	coref	22-27[224_198]
19-32	4391-4397	cliffs	place[194]|place[196]|object[198]	new[194]|new[196]|new[198]	_	_
19-33	4398-4401	and	place[194]|place[196]	new[194]|new[196]	_	_
19-34	4402-4407	stony	place[194]|place[196]|object[199]	new[194]|new[196]|new[199]	coref	23-3[227_199]
19-35	4408-4415	bridges	place[194]|place[196]|object[199]	new[194]|new[196]|new[199]	_	_
19-36	4416-4417	.	_	_	_	_

#Text=Geographically , a successful voyage ( or exploration ) requires a map indicating smooth and flat regions that are easy to navigate or jagged parts that are tough to traverse .
20-1	4418-4432	Geographically	_	_	_	_
20-2	4433-4434	,	_	_	_	_
20-3	4435-4436	a	event[200]	new[200]	_	_
20-4	4437-4447	successful	event[200]	new[200]	_	_
20-5	4448-4454	voyage	event[200]	new[200]	_	_
20-6	4455-4456	(	_	_	_	_
20-7	4457-4459	or	_	_	_	_
20-8	4460-4471	exploration	event	new	_	_
20-9	4472-4473	)	_	_	_	_
20-10	4474-4482	requires	_	_	_	_
20-11	4483-4484	a	object[202]	new[202]	_	_
20-12	4485-4488	map	object[202]	new[202]	_	_
20-13	4489-4499	indicating	object[202]	new[202]	_	_
20-14	4500-4506	smooth	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	coref|coref	20-14[204_203]|22-11[220_204]
20-15	4507-4510	and	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-16	4511-4515	flat	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-17	4516-4523	regions	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-18	4524-4528	that	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-19	4529-4532	are	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-20	4533-4537	easy	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-21	4538-4540	to	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-22	4541-4549	navigate	object[202]|place[203]|place[204]	new[202]|giv[203]|giv[204]	_	_
20-23	4550-4552	or	object[202]|place[204]	new[202]|giv[204]	_	_
20-24	4553-4559	jagged	object[202]|place[204]|object[205]	new[202]|giv[204]|new[205]	_	_
20-25	4560-4565	parts	object[202]|place[204]|object[205]	new[202]|giv[204]|new[205]	_	_
20-26	4566-4570	that	object[202]|place[204]|object[205]	new[202]|giv[204]|new[205]	_	_
20-27	4571-4574	are	object[202]|place[204]|object[205]	new[202]|giv[204]|new[205]	_	_
20-28	4575-4580	tough	object[202]|place[204]|object[205]	new[202]|giv[204]|new[205]	_	_
20-29	4581-4583	to	object[202]|place[204]|object[205]	new[202]|giv[204]|new[205]	_	_
20-30	4584-4592	traverse	object[202]|place[204]|object[205]	new[202]|giv[204]|new[205]	_	_
20-31	4593-4594	.	_	_	_	_

#Text=Chemically , gently sloped hills pinpoint areas where gradual structural variations are accompanied by moderate changes in activity , whereas in flat SAR landscapes , the biological data varies little over the wide modifications in the compound structure — further substitutions are not likely to result in more potent molecules .
21-1	4595-4605	Chemically	_	_	_	_
21-2	4606-4607	,	_	_	_	_
21-3	4608-4614	gently	object[206]	new[206]	_	_
21-4	4615-4621	sloped	object[206]	new[206]	_	_
21-5	4622-4627	hills	object[206]	new[206]	_	_
21-6	4628-4636	pinpoint	_	_	_	_
21-7	4637-4642	areas	place[207]	new[207]	_	_
21-8	4643-4648	where	place[207]	new[207]	_	_
21-9	4649-4656	gradual	place[207]|abstract[208]	new[207]|giv[208]	coref	22-22[223_208]
21-10	4657-4667	structural	place[207]|abstract[208]	new[207]|giv[208]	_	_
21-11	4668-4678	variations	place[207]|abstract[208]	new[207]|giv[208]	_	_
21-12	4679-4682	are	place[207]	new[207]	_	_
21-13	4683-4694	accompanied	place[207]	new[207]	_	_
21-14	4695-4697	by	place[207]	new[207]	_	_
21-15	4698-4706	moderate	place[207]|abstract[209]	new[207]|giv[209]	_	_
21-16	4707-4714	changes	place[207]|abstract[209]	new[207]|giv[209]	_	_
21-17	4715-4717	in	place[207]|abstract[209]	new[207]|giv[209]	_	_
21-18	4718-4726	activity	place[207]|abstract[209]|abstract	new[207]|giv[209]|giv	coref	22-31
21-19	4727-4728	,	_	_	_	_
21-20	4729-4736	whereas	_	_	_	_
21-21	4737-4739	in	_	_	_	_
21-22	4740-4744	flat	abstract[212]	giv[212]	_	_
21-23	4745-4748	SAR	abstract|abstract[212]	giv|giv[212]	coref	23-13
21-24	4749-4759	landscapes	abstract[212]	giv[212]	_	_
21-25	4760-4761	,	_	_	_	_
21-26	4762-4765	the	abstract[213]	giv[213]	_	_
21-27	4766-4776	biological	abstract[213]	giv[213]	_	_
21-28	4777-4781	data	abstract[213]	giv[213]	_	_
21-29	4782-4788	varies	_	_	_	_
21-30	4789-4795	little	_	_	_	_
21-31	4796-4800	over	_	_	_	_
21-32	4801-4804	the	abstract[214]	giv[214]	coref	22-4[219_214]
21-33	4805-4809	wide	abstract[214]	giv[214]	_	_
21-34	4810-4823	modifications	abstract[214]	giv[214]	_	_
21-35	4824-4826	in	abstract[214]	giv[214]	_	_
21-36	4827-4830	the	abstract[214]|abstract[216]	giv[214]|giv[216]	coref	25-24[0_216]
21-37	4831-4839	compound	abstract[214]|substance|abstract[216]	giv[214]|giv|giv[216]	_	_
21-38	4840-4849	structure	abstract[214]|abstract[216]	giv[214]|giv[216]	_	_
21-39	4850-4851	—	_	_	_	_
21-40	4852-4859	further	abstract[217]	new[217]	_	_
21-41	4860-4873	substitutions	abstract[217]	new[217]	_	_
21-42	4874-4877	are	_	_	_	_
21-43	4878-4881	not	_	_	_	_
21-44	4882-4888	likely	_	_	_	_
21-45	4889-4891	to	_	_	_	_
21-46	4892-4898	result	_	_	_	_
21-47	4899-4901	in	_	_	_	_
21-48	4902-4906	more	substance[218]	giv[218]	coref	23-9[228_218]
21-49	4907-4913	potent	substance[218]	giv[218]	_	_
21-50	4914-4923	molecules	substance[218]	giv[218]	_	_
21-51	4924-4925	.	_	_	_	_

#Text=In fact , disallowed structural modifications can be highlighted in the sharply non-uniform regions where chemically related compounds are characterized by huge response variations , forming steep cliffs in the activity landscape .
22-1	4926-4928	In	_	_	_	_
22-2	4929-4933	fact	_	_	_	_
22-3	4934-4935	,	_	_	_	_
22-4	4936-4946	disallowed	abstract[219]	giv[219]	_	_
22-5	4947-4957	structural	abstract[219]	giv[219]	_	_
22-6	4958-4971	modifications	abstract[219]	giv[219]	_	_
22-7	4972-4975	can	_	_	_	_
22-8	4976-4978	be	_	_	_	_
22-9	4979-4990	highlighted	_	_	_	_
22-10	4991-4993	in	_	_	_	_
22-11	4994-4997	the	place[220]	giv[220]	_	_
22-12	4998-5005	sharply	place[220]	giv[220]	_	_
22-13	5006-5017	non-uniform	place[220]	giv[220]	_	_
22-14	5018-5025	regions	place[220]	giv[220]	_	_
22-15	5026-5031	where	place[220]	giv[220]	_	_
22-16	5032-5042	chemically	place[220]|substance[221]	giv[220]|new[221]	_	_
22-17	5043-5050	related	place[220]|substance[221]	giv[220]|new[221]	_	_
22-18	5051-5060	compounds	place[220]|substance[221]	giv[220]|new[221]	_	_
22-19	5061-5064	are	place[220]	giv[220]	_	_
22-20	5065-5078	characterized	place[220]	giv[220]	_	_
22-21	5079-5081	by	place[220]	giv[220]	_	_
22-22	5082-5086	huge	place[220]|abstract[223]	giv[220]|giv[223]	_	_
22-23	5087-5095	response	place[220]|abstract|abstract[223]	giv[220]|giv|giv[223]	_	_
22-24	5096-5106	variations	place[220]|abstract[223]	giv[220]|giv[223]	_	_
22-25	5107-5108	,	_	_	_	_
22-26	5109-5116	forming	_	_	_	_
22-27	5117-5122	steep	object[224]	giv[224]	coref	25-5[244_224]
22-28	5123-5129	cliffs	object[224]	giv[224]	_	_
22-29	5130-5132	in	object[224]	giv[224]	_	_
22-30	5133-5136	the	object[224]|abstract[226]	giv[224]|giv[226]	coref	25-27[0_226]
22-31	5137-5145	activity	object[224]|abstract|abstract[226]	giv[224]|giv|giv[226]	coref	24-5
22-32	5146-5155	landscape	object[224]|abstract[226]	giv[224]|giv[226]	_	_
22-33	5156-5157	.	_	_	_	_

#Text=Moreover , chemical bridges can be observed with molecules connecting different local SAR models .
23-1	5158-5166	Moreover	_	_	_	_
23-2	5167-5168	,	_	_	_	_
23-3	5169-5177	chemical	object[227]	giv[227]	_	_
23-4	5178-5185	bridges	object[227]	giv[227]	_	_
23-5	5186-5189	can	_	_	_	_
23-6	5190-5192	be	_	_	_	_
23-7	5193-5201	observed	_	_	_	_
23-8	5202-5206	with	_	_	_	_
23-9	5207-5216	molecules	substance[228]	giv[228]	_	_
23-10	5217-5227	connecting	substance[228]	giv[228]	_	_
23-11	5228-5237	different	substance[228]|abstract[230]	giv[228]|giv[230]	_	_
23-12	5238-5243	local	substance[228]|abstract[230]	giv[228]|giv[230]	_	_
23-13	5244-5247	SAR	substance[228]|abstract|abstract[230]	giv[228]|giv|giv[230]	coref	25-37
23-14	5248-5254	models	substance[228]|abstract[230]	giv[228]|giv[230]	_	_
23-15	5255-5256	.	_	_	_	_

#Text=The detection of the activity hotspots provides reasonable hints to the key question of medicinal chemistry regarding the impact of molecule rearrangement on the activity profile .
24-1	5257-5260	The	abstract[231]	new[231]	_	_
24-2	5261-5270	detection	abstract[231]	new[231]	_	_
24-3	5271-5273	of	abstract[231]	new[231]	_	_
24-4	5274-5277	the	abstract[231]|place[233]	new[231]|new[233]	_	_
24-5	5278-5286	activity	abstract[231]|abstract|place[233]	new[231]|giv|new[233]	coref	24-25
24-6	5287-5295	hotspots	abstract[231]|place[233]	new[231]|new[233]	_	_
24-7	5296-5304	provides	_	_	_	_
24-8	5305-5315	reasonable	abstract[234]	new[234]	_	_
24-9	5316-5321	hints	abstract[234]	new[234]	_	_
24-10	5322-5324	to	abstract[234]	new[234]	_	_
24-11	5325-5328	the	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
24-12	5329-5332	key	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
24-13	5333-5341	question	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
24-14	5342-5344	of	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
24-15	5345-5354	medicinal	abstract[234]|abstract[235]|abstract[236]	new[234]|giv[235]|new[236]	_	_
24-16	5355-5364	chemistry	abstract[234]|abstract[235]|abstract[236]	new[234]|giv[235]|new[236]	_	_
24-17	5365-5374	regarding	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
24-18	5375-5378	the	abstract[234]|abstract[235]|abstract[237]	new[234]|giv[235]|new[237]	_	_
24-19	5379-5385	impact	abstract[234]|abstract[235]|abstract[237]	new[234]|giv[235]|new[237]	_	_
24-20	5386-5388	of	abstract[234]|abstract[235]|abstract[237]	new[234]|giv[235]|new[237]	_	_
24-21	5389-5397	molecule	abstract[234]|abstract[235]|abstract[237]|substance|abstract[239]	new[234]|giv[235]|new[237]|new|new[239]	_	_
24-22	5398-5411	rearrangement	abstract[234]|abstract[235]|abstract[237]|abstract[239]	new[234]|giv[235]|new[237]|new[239]	_	_
24-23	5412-5414	on	abstract[234]|abstract[235]|abstract[237]	new[234]|giv[235]|new[237]	_	_
24-24	5415-5418	the	abstract[234]|abstract[235]|abstract[237]|abstract[241]	new[234]|giv[235]|new[237]|new[241]	_	_
24-25	5419-5427	activity	abstract[234]|abstract[235]|abstract[237]|abstract|abstract[241]	new[234]|giv[235]|new[237]|giv|new[241]	coref	25-5
24-26	5428-5435	profile	abstract[234]|abstract[235]|abstract[237]|abstract[241]	new[234]|giv[235]|new[237]|new[241]	_	_
24-27	5436-5437	.	_	_	_	_

#Text=The numerical quantification of activity cliffs is frequently performed using a variety of fingerprint representations or similarity metrics ; for instance , the structure – activity landscape index ( SALI ) has been proposed to evaluate SAR smoothness .
25-1	5438-5441	The	abstract[242]	giv[242]	_	_
25-2	5442-5451	numerical	abstract[242]	giv[242]	_	_
25-3	5452-5466	quantification	abstract[242]	giv[242]	_	_
25-4	5467-5469	of	abstract[242]	giv[242]	_	_
25-5	5470-5478	activity	abstract[242]|abstract|object[244]	giv[242]|giv|giv[244]	coref	25-26
25-6	5479-5485	cliffs	abstract[242]|object[244]	giv[242]|giv[244]	_	_
25-7	5486-5488	is	_	_	_	_
25-8	5489-5499	frequently	_	_	_	_
25-9	5500-5509	performed	_	_	_	_
25-10	5510-5515	using	_	_	_	_
25-11	5516-5517	a	abstract[245]	new[245]	_	_
25-12	5518-5525	variety	abstract[245]	new[245]	_	_
25-13	5526-5528	of	abstract[245]	new[245]	_	_
25-14	5529-5540	fingerprint	abstract[245]|substance|abstract[247]	new[245]|new|new[247]	_	_
25-15	5541-5556	representations	abstract[245]|abstract[247]	new[245]|new[247]	_	_
25-16	5557-5559	or	abstract[245]	new[245]	_	_
25-17	5560-5570	similarity	abstract[245]|abstract|abstract[249]	new[245]|giv|giv[249]	_	_
25-18	5571-5578	metrics	abstract[245]|abstract[249]	new[245]|giv[249]	_	_
25-19	5579-5580	;	_	_	_	_
25-20	5581-5584	for	_	_	_	_
25-21	5585-5593	instance	_	_	_	_
25-22	5594-5595	,	_	_	_	_
25-23	5596-5599	the	abstract[253]	new[253]	appos	25-30[0_253]
25-24	5600-5609	structure	abstract|abstract[253]	giv|new[253]	_	_
25-25	5610-5611	–	abstract[253]	new[253]	_	_
25-26	5612-5620	activity	abstract|abstract[253]	giv|new[253]	_	_
25-27	5621-5630	landscape	abstract|abstract[253]	giv|new[253]	_	_
25-28	5631-5636	index	abstract[253]	new[253]	_	_
25-29	5637-5638	(	_	_	_	_
25-30	5639-5643	SALI	abstract	giv	_	_
25-31	5644-5645	)	_	_	_	_
25-32	5646-5649	has	_	_	_	_
25-33	5650-5654	been	_	_	_	_
25-34	5655-5663	proposed	_	_	_	_
25-35	5664-5666	to	_	_	_	_
25-36	5667-5675	evaluate	_	_	_	_
25-37	5676-5679	SAR	abstract|abstract[256]	giv|new[256]	_	_
25-38	5680-5690	smoothness	abstract[256]	new[256]	_	_
25-39	5691-5692	.	_	_	_	_
